Wednesday, January 24, 2018 5:25:56 PM
Seems all casino plays are catching a nice run up................
Century Casinos started at buy with $13 stock price target at Stifel Nicolaus
Jan. 10, 2018 at 8:17 a.m. ET by Tomi Kilgore
Century Casinos initiated at Stifel Century Casinos initiated with a Buy at Stifel. Stifel analyst Steven Wieczynski started Century Casinos with a Buy rating and $13 price target. The analyst believes believe investors have largely ignored the near-term EBITDA growth opportunity created by the company's $60M development pipeline. He sees a "compelling investment opportunity" with modeled 12-month return potential in excess of 40%.
Recent CNTY News
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/14/2024 02:07:11 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/12/2024 05:45:23 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 10/04/2023 08:27:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/15/2023 08:25:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/14/2023 08:43:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/13/2023 08:37:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/13/2023 08:35:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/13/2023 08:34:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/13/2023 08:32:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/13/2023 08:31:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/06/2023 08:17:41 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/25/2023 08:17:23 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM